These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome. Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898 [TBL] [Abstract][Full Text] [Related]
5. [Anti-GD1b IgG positive case of overlapping Ficher's and Guillain-Barré syndromes]. Caudie C; Schandelong A; Rapoport F; Vial C Ann Biol Clin (Paris); 2004; 62(5):591-4. PubMed ID: 15355812 [TBL] [Abstract][Full Text] [Related]
6. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Kuwahara M; Suzuki S; Takada K; Kusunoki S J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557 [TBL] [Abstract][Full Text] [Related]
8. Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome. Bonyadi MR; Barzegar M; Badalzadeh R; Hashemilar M Iran J Immunol; 2010 Jun; 7(2):117-23. PubMed ID: 20574125 [TBL] [Abstract][Full Text] [Related]
9. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies. Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies. Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437 [TBL] [Abstract][Full Text] [Related]
11. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome. Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979 [TBL] [Abstract][Full Text] [Related]
13. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome. Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757 [TBL] [Abstract][Full Text] [Related]